皮肌炎中的抗SAE自身抗体:原创比较研究与文献综述
这项回顾性观察研究从19个中心招募抗SAE抗体阳性皮肌炎患者49例,描述其临床特征、肿瘤患病率和肌肉病理,并与抗SAE阴性皮肌炎85例比较及复习文献。抗SAE阳性患者以典型皮肤受累(96%)和轻度肌病为特征,肿瘤相关肌炎占16%,患病率为一般人群的五倍。
要点
- 抗SAE阳性皮肌炎患者中皮肤受累占96%,肌肉受累占84%,肌无力以轻度为主。
- 抗SAE阳性患者中肿瘤相关肌炎占16%,其患病率为一般人群的五倍。
- 与抗SAE阴性皮肌炎相比,抗SAE阳性患者肌无力更少更轻、肌酸激酶更低、呼吸困难更少。
核心结论
- 抗SAE阳性皮肌炎是罕见亚组,与典型皮肤特征但可能弥漫性皮疹及轻度肌病相关。
- 间质性肺病表现为机化性肺炎模式。
- 肿瘤相关皮肌炎患病率为一般人群的五倍。
研究设计与样本
- 回顾性观察研究,从19个中心招募确诊皮肌炎且血清抗SAE抗体阳性的患者49例。
- 对可获得的肌肉活检进行复核,并与抗SAE阴性皮肌炎85例比较,同时复习文献。
- 试验注册号NCT04637672。
主要发现
- 49例患者中女性占84%;皮肤受累典型者占96%,其中钙质沉着占10%、溃疡占18%、坏死占12%,35%表现为广泛性皮疹。
- 肌肉受累占84%,肌无力程度为轻度[医学研究理事会(MRC)量表4(3,5)],39%的患者有吞咽困难。
- 肌肉活检显示典型皮肌炎病变;间质性肺病占21%,主要为机化性肺炎模式,26%的患者有呼吸困难。
- 肿瘤相关肌炎占16%,是大多数死亡的原因,其患病率为一般人群的五倍。
- 病程中51%的患者接受IVIG治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Among specific autoantibodies in DM, the anti-small ubiquitin-like modifier activating enzyme (SAE) antibody is rare. We aim to describe the clinical characteristics, cancer prevalence, and muscle pathology of anti-SAE-positive DM. METHODS: Patients with a diagnosis of DM and sera positive for the anti-SAE antibody were recruited from 19 centres in this retrospective observational study. The available muscular biopsies were reviewed. We conducted a comparison with anti-SAE-negative DM and a review of the literature. RESULTS: Of the patients in the study (n = 49), 84% were women. Skin involvement was typical in 96% of patients, with 10% having calcinosis, 18% ulceration and 12% necrosis; 35% presented with a widespread skin rash. Muscular disease affected 84% of patients, with mild weakness [Medical Research Council (MRC) scale 4 (3, 5)], although 39% of patients had dysphagia. Muscular biopsies showed typical DM lesions. Interstitial lung disease was found in 21% of patients, mainly with organizing pneumonia pattern, and 26% of patients showed dyspnoea. Cancer-associated myositis was diagnosed in 16% of patients and was responsible for the majority of deaths, its prevalence being five times that of the general population. IVIG therapy was administered to 51% of the patients during the course of the disease. Comparison with anti-SAE-negative DM (n = 85) showed less and milder muscle weakness (P = 0.02 and P = 0.006, respectively), lower creatinine kinase levels (P < 0.0001) and less dyspnoea (P = 0.003). CONCLUSION: Anti-SAE positive DM is a rare subgroup associated with typical skin features but a potentially diffuse rash, a mild myopathy. Interstitial lung disease defines an organizing pneumonia pattern. Cancer associated DM prevalence is five times that of the general population. TRIAL REGISTRATION: ClinicalTrials.gov, http://clinicaltrials.gov, NCT04637672.
引用
- Demortier J, Vautier M, Chosidow O, et al. Anti-SAE autoantibody in dermatomyositis: original comparative study and review of the literature. Rheumatology (Oxford). 2023. PMID: 37010495. doi:10.1093/rheumatology/kead154
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。